ASP3662

ASP3662 · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP3662, covering 2016-06-28 to 2016-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662 [Phase 1]

See pricing